NCT03093116 2025-07-10TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 2 FDA
NCT04949282 2022-12-23SEPTRALUSociedad Española de Medicina Nuclear e Imagen MolecularRecruiting5,000 enrolled